A Comparison of Ocular Complications after 0.7 mg Dexamethasone Implant versus 2 mg of Intravitreal Triamcinolone in Vitrectomized Eyes

被引：0
|
作者：
Wakabayashi, Taku
Liu, Catherine K.
Anderson, Hannah E.
Mahmoudzadeh, Raziyeh
Nguyen, Michael K.
Salabati, Mirataollah
Chiang, Allen
Hsu, Jason
Garg, Sunir J.
Spirn, Marc J.
机构：
来源：
OPHTHALMOLOGY | 2023年 / 130卷 / 07期
关键词：
D O I：
暂无
中图分类号：
R77 [眼科学];
学科分类号：
100212 ;
摘要：
引用
收藏
页码：660 / 661
页数：2
相关论文
共 50 条
  • [21] Incidence of ocular hypertension following intravitreal injection of 2mg triamcinolone
    Storey, Philip
    Obeid, Anthony
    Pancholy, Maitri
    Goodman, Jake
    Gao, Xinxiao
    Borkar, Durga S.
    Su, Daniel
    Regillo, Carl
    INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE, 2018, 59 (09)
  • [22] Retrospective Study of Two or More Dexamethasone Intravitreal Implant 0.7 mg Injections for Retinal Vein Occlusion
    Capone, Antonio
    Singer, Michael
    Dodwell, David
    Dreyer, Richard
    Oh, Kean
    Roth, Daniel
    Walt, John
    Scott, Lanita
    Hollander, David
    INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE, 2013, 54 (15)
  • [23] Results of Intravitreal Dexamethasone Implant 0.7mg ( Ozurdex) in non-infectious posterior uveitis
    Yap, Yew Chong
    Papathomas, Thomas
    Ahmed, Kamal
    INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE, 2013, 54 (15)
  • [24] Treatment of postoperative cystoid macular edema (Irvine-Gass syndrome) with dexamethasone 0.7 mg intravitreal implant
    Landre, C.
    Zourdani, A.
    Gastaud, P.
    Baillif, S.
    JOURNAL FRANCAIS D OPHTALMOLOGIE, 2016, 39 (01): : 5 - 11
  • [25] Real-world assessment of intravitreal dexamethasone implant (0.7 mg) in patients with macular edema: the CHROME study
    Lam, Wai-Ching
    Albiani, David A.
    Yoganathan, Pradeepa
    Chen, John Chanchiang
    Kherani, Amin
    Maberley, David A. L.
    Oliver, Alejandro
    Rabinovitch, Theodore
    Sheidow, Thomas G.
    Tourville, Eric
    Wittenberg, Leah A.
    Sigouin, Chris
    Baptiste, Darryl C.
    CLINICAL OPHTHALMOLOGY, 2015, 9 : 1255 - 1268
  • [26] Intravitreal triamcinolone for diabetic macular edema - Comparison of 1, 2, and 4 mg
    Hauser, David
    Bukelman, Amir
    Pokroy, Russell
    Katz, Haia
    Len, Ariela
    Thein, Ran
    Parness-Yossifon, Rehut
    Pollack, Ayala
    RETINA-THE JOURNAL OF RETINAL AND VITREOUS DISEASES, 2008, 28 (06): : 825 - 830
  • [27] Evaluation of Functional Outcomes and OCT-Biomarkers after Intravitreal Dexamethasone Implant for Postoperative Cystoid Macular Edema in Vitrectomized Eyes
    Freissinger, Sigrid
    Vounotrypidis, Efstathios
    Wolf, Armin
    Kortuem, Karsten U.
    Shajari, Mehdi
    Sakkias, Filippos
    Herold, Tina
    Priglinger, Siegfried G.
    Mayer, Wolfgang J.
    JOURNAL OF OPHTHALMOLOGY, 2020, 2020
  • [28] Secondary ocular hypertension after intravitreal injection of 4 mg of triamcinolone acetonide - Incidence and risk factors
    Vasconcelos-Santos, Daniel V.
    Nehemy, Patricia G.
    Schachat, Andrew P.
    Nehemy, Marcio B.
    RETINA-THE JOURNAL OF RETINAL AND VITREOUS DISEASES, 2008, 28 (04): : 573 - 580
  • [29] Dexamethasone 0.7-mg intravitreal implant in patients with radiation macular edema after proton beam therapy for choroidal melanoma: 2-year results
    Baillif, S.
    Maschi, C.
    Caujolle, J. P.
    ACTA OPHTHALMOLOGICA, 2015, 93
  • [30] Radiation Macular Edema after Ru-106 Plaque Brachytherapy for Choroidal Melanoma Resolved by an Intravitreal Dexamethasone 0.7-mg Implant
    Russo, Andrea
    Avitabile, Teresio
    Uva, Maurizio
    Faro, Salvatore
    Franco, Livio
    Sanfilippo, Marisa
    Gulisano, Seby
    Toro, Mario
    De Grande, Vittorio
    Rametta, Stefania
    Foti, Laura
    Longo, Antonio
    Reibaldi, Michele
    CASE REPORTS IN OPHTHALMOLOGY, 2012, 3 (01): : 71 - 76
12345